Publisher: EDRA SpA   (Total: 1 journals)   [Sort by number of followers]

Showing 1 - 1 of 1 Journals sorted alphabetically
European Annals of Allergy and Clinical Immunology     Open Access   (Followers: 4, SJR: 0.441, CiteScore: 1)
Similar Journals
Journal Cover
European Annals of Allergy and Clinical Immunology
Journal Prestige (SJR): 0.441
Citation Impact (citeScore): 1
Number of Followers: 4  

  This is an Open Access Journal Open Access journal
ISSN (Print) 1764-1489
Published by EDRA SpA Homepage  [1 journal]
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 02 Feb 2023 02:05:04 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 28 Jan 2023 11:06:22 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 24 Jan 2023 08:59:48 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Dupilumab to induce tolerance to SLIT-Melocot ón®

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions in our case our aim is to achieve SLIT. We report a case of compassionate use with Dupilumab in a patient with multiple food allergy syndrome mediated by nsLTP. There are no cases reported for Dupilumab in this use.PMID:36637172
      DOI :10.23822/EurAnnACI.1764-1489.280 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • The clinical and laboratory findings of infants with atopic dermatitis
           during diagnosis and follow-up

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Food allergy is more common in the early-onset and moderate/severe atopic dermatitis. Accurate diagnosis of food allergy is necessary to increase the success of treatment and to prevent unnecessary diets.PMID:36637173
      DOI :10.23822/EurAnnACI.1764-1489.281 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Skin Atrophy after diagnostic tests with corticosteroids for the diagnosis
           of SARS-CoV-2 vaccine excipients hypersensitivity

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 13. doi: 10.23822/EurAnnACI.1764-1489.282. Online ahead of print.NO ABSTRACTPMID:36637174
      DOI :10.23822/EurAnnACI.1764-1489.282 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Hypersensitivity to Vespa velutina nigrithorax: an emerging problem in
           Portugal'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2023 Jan 4. doi: 10.23822/EurAnnACI.1764-1489.279. Online ahead of print.NO ABSTRACTPMID:36633159
      DOI :10.23822/EurAnnACI.1764-1489.279 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Wed, 18 Jan 2023 06:01:26 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Wed, 11 Jan 2023 09:32:13 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 05 Jan 2023 19:14:24 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 30 Dec 2022 21:54:19 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Fri, 30 Dec 2022 21:54:19 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn), co
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Fri, 30 Dec 2022 21:54:19 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.ABSTRACTThe use of acetylsalicylic acid (ASA) desensitization for patients with coronary artery disease (CAD) is growing, but no data are available on desensitization protocol in patients with ASA sensitivity and CAD during pregnancy. This case report shows that ASA desensitization protocol during pregnancy could be safe and effective in a tertiary centre with a multidisciplinary team.PMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.ABSTRACTVespa velutina nigrithorax (VVN), commonly known as Asian wasp because endemic in Asia, represents an alien species in Europe. VVN can induce allergic reactions similar to those caused by other Hymenoptera and deaths after VVN stings, presumably due to fatal allergic reactions, were reported. In the treatment of Hymenoptera venom hypersensitivity, specific immunotherapy (VIT) is highly effective, and the vaccine allergen-specificity plays a crucial role. Currently, there is no specific available VIT for VVN, so VVN stung patients with severe systemic reactions are treated with Vespula spp (Vspp) venom. It is also relevant to assess if patients stung by VVN and showing allergic re...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.277. online ahead of print.abstractvespa velutina nigrithorax (vvn) com
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.ABSTRACTHereditary angioedema (HAE) poses a high burden of disease, being its epidemiological and clinical data heterogeneous among countries, with no recent published studies concerning Portuguese patients. Therefore, we aimed to raise awareness of HAE and to contribute to clinical knowledge. An observational, descriptive, retrospective, and cross-sectional study was performed, that included a cohort of 126 patients followed in a single Portuguese Center. We observed a high prevalence of HAE-C1-INH type II (45.2% of patients). Most HAE patients (67.4%) presented the initial manifestations of the disease before adulthood, at a mean age of 12.6 ± 8.4 years. However, we found a long delay...
      PubDate: Thu, 29 Dec 2022 11:18:33 +010
      DOI: 10.23822/eurannaci.1764-1489.278. online ahead of print.abstracthereditary angioedema (hae) poses a
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.NO ABSTRACTPMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.NO ABSTRACTPMID:36515256
      DOI :10.23822/EurAnnACI.1764-1489.277 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.NO ABSTRACTPMID:36515257
      DOI :10.23822/EurAnnACI.1764-1489.278 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.NO ABSTRACTPMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.NO ABSTRACTPMID:36515256
      DOI :10.23822/EurAnnACI.1764-1489.277 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.NO ABSTRACTPMID:36515257
      DOI :10.23822/EurAnnACI.1764-1489.278 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.NO ABSTRACTPMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.NO ABSTRACTPMID:36515256
      DOI :10.23822/EurAnnACI.1764-1489.277 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.NO ABSTRACTPMID:36515257
      DOI :10.23822/EurAnnACI.1764-1489.278 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.NO ABSTRACTPMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.NO ABSTRACTPMID:36515256
      DOI :10.23822/EurAnnACI.1764-1489.277 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.NO ABSTRACTPMID:36515257
      DOI :10.23822/EurAnnACI.1764-1489.278 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.NO ABSTRACTPMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.NO ABSTRACTPMID:36515256
      DOI :10.23822/EurAnnACI.1764-1489.277 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.NO ABSTRACTPMID:36515257
      DOI :10.23822/EurAnnACI.1764-1489.278 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 23 Dec 2022 23:49:31 +010
       
  • Acetylsalicylic acid (ASA) desensitization in an allergic pregnant woman
           post-vascular scaffolds implantation

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.276. Online ahead of print.NO ABSTRACTPMID:36515255
      DOI :10.23822/EurAnnACI.1764-1489.276 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Vespa velutina nigrithorax venom allergy: inhibition studies approach for
           the choice of specific immunotherapy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 13. doi: 10.23822/EurAnnACI.1764-1489.277. Online ahead of print.NO ABSTRACTPMID:36515256
      DOI :10.23822/EurAnnACI.1764-1489.277 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Hereditary angioedema: 24 years of experience in a Portuguese Reference
           Center

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 14. doi: 10.23822/EurAnnACI.1764-1489.278. Online ahead of print.NO ABSTRACTPMID:36515257
      DOI :10.23822/EurAnnACI.1764-1489.278 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 16 Dec 2022 08:56:24 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 10 Dec 2022 08:57:56 +010
       
  • Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance
           approach

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Nov 15. doi: 10.23822/EurAnnACI.1764-1489.273. Online ahead of print.NO ABSTRACTPMID:36458479
      DOI :10.23822/EurAnnACI.1764-1489.273 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 03 Dec 2022 19:38:05 +010
       
  • Penicillin Allergy label - the unmet needs - causes and potential
           solutions

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.274. Online ahead of print.NO ABSTRACTPMID:36458480
      DOI :10.23822/EurAnnACI.1764-1489.274 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 03 Dec 2022 19:38:05 +010
       
  • Polythylene glycol severe allergy and SARS-CoV-2 vaccines: usefulness of
           testing with PEG 1500 extract

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Dec 2. doi: 10.23822/EurAnnACI.1764-1489.275. Online ahead of print.NO ABSTRACTPMID:36458507
      DOI :10.23822/EurAnnACI.1764-1489.275 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 03 Dec 2022 19:38:05 +010
       
  • D-dimer levels decline after immunosuppressive treatment rather than
           anticoagulant treatment in severe autoimmune chronic spontaneous urticaria
           

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Oct 28. doi: 10.23822/EurAnnACI.1764-1489.272. Online ahead of print.NO ABSTRACTPMID:36305339
      DOI :10.23822/EurAnnACI.1764-1489.272 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 03 Dec 2022 19:38:05 +010
       
  • From triggers to asthma: a narrative review on epithelium dysfunction

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: This article reviews the pathophysiology and functions of the airway epithelium and the role of epithelial damage by different triggers in the development, persistence, and exacerbations of asthma.PMID:36214074
      DOI :10.23822/EurAnnACI.1764-1489.271 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 29 Oct 2022 04:20:56 +010
       
  • Association of asthma risk factors and the prevalence of the disease in a
           population of Brazil

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: The objective of our study was to evaluate the association between the previously described asthma risk factors and the prevalence of asthma in a population of Brazilian adults. A population-based cross-sectional study was conducted using data collected from 7891 patients. All patients in the database > 18 years of age were included. The following variables were collected from the health plan database: age, body mass index, smoking status, alcohol consumption, sedentary lifestyle, heart disease, hypertension, diabetes, and asthma diagnosis. The frequency of the collected variables was compared between patients with or without an asthma diagnosis, and logistic regression was performed. Of our total sample (7891 patients), 150 (1.9%) had asthma. The mean age of patients with asthma was 39...
      PubDate: Sun, 16 Oct 2022 02:09:41 +010
       
  • Sensitization to genuine markers of timothy grass pollen (Phleum pratense)
           in the North-Central region of Portugal

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Sep 29. doi: 10.23822/EurAnnACI.1764-1489.269. Online ahead of print.ABSTRACTPollens are the main cause of respiratory allergies which prevalence is increasing. The most important cause of pollinosis in Europe and especially in the Mediterranean countries as Portugal is Poaceae family pollen. Timothy grass (Phleum pratense) is one of the most common pollen sources, and one of the best characterized allergenic grasses. The major allergens Phl p1 and Phl p5 are considered markers of genuine grass pollen sensitization. A characterization of Phl p1 and Phl p5 sensitization in the North-Central region of Portugal was made in children and adults. Phl p1 sensitization was the most frequent.PMID:36173320
      DOI :10.23822/EurAnnACI.1764-1489.269 (Source: European An...
      PubDate: Mon, 10 Oct 2022 20:01:13 +010
       
  • Posterior nasal nerve neurectomy for the treatment of rhinitis: a
           Systematic Review and Meta-Analysis

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. This systematic review identified there is some limited evidence to suggest cryotherapy or radiofrequency ablation of the posterior nasal nerve can improve TNSS in adult patients. However, this is from a limited number of trials with short follow-up. Future research should focus on prospective randomised controlled trials with larger numbers of participants and medium to long term follow up in order to help draw more valid conclusions regarding the true effectiveness of PNNN in this patient cohort.PMID:36066203
      DOI :10.23822/EurAnnACI.1764-1489.268 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 05 Oct 2022 03:14:18 +010
       
  • Taxanes Hypersensitivity is not a risk factor for severe reactions to
           SARS-Cov-2 Vaccines

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. In our cohort Patients with history of reaction to taxanes were not at higher risk to develop anaphylaxis to SARS-CoV-2 vaccines. However, a common non-IgE mediated mechanism behind those HSRs cannot be completely excluded. This can only account for mild and harmless symptoms in case of SARS-CoV-2 vaccines. Antihistamine premedication and longer observation after the vaccination are still prudent in these patients.PMID:36047485
      DOI :10.23822/EurAnnACI.1764-1489.265 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 07 Sep 2022 16:39:46 +010
       
  • Prenatal antibiotic exposure increases the risk of infant atopic
           dermatitis. Data from a Greek cohort

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Αn increased risk of AD was recorded only when antibiotics were given prenatally by intravenous route and in women between 30-40 years of age. Children with food allergy had an increased risk for AD. The relatively high percentage of caesarean sections was not a risk factor for AD.PMID:36047711
      DOI :10.23822/EurAnnACI.1764-1489.266 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 07 Sep 2022 16:39:46 +010
       
  • Clinical evaluation of subcutaneous immunotherapy with a polymerized
           molecular allergoid of Alt a 1 in patients with allergic
           rhinoconjunctivitis and/or allergic asthma caused by the mould < em>
           Alternaria alternata < /em>

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Sep 1. doi: 10.23822/EurAnnACI.1764-1489.267. Online ahead of print.ABSTRACTThis is a retrospective analysis of the clinical evolution of 14 patients diagnosed with allergic rhinoconjunctivitis (AR) and/or allergic asthma (AA) caused by Alternaria alternata, who were attended by the allergology service of Vega Baja Hospital of Orihuela (Alicante, Spain). The purpose was to assess the clinical impact and safety of 1-year of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1. Impact of the treatment on allergic diseases (mean number AR/AA episodes and ARIA/GINA classifications), changes in symptoms and prescribed medication, change in the global subjective clinical status of patients and satisfaction with the treatment were also ev...
      PubDate: Wed, 07 Sep 2022 16:39:46 +010
      DOI: 10.23822/eurannaci.1764-1489.267. online ahead of print.abstractthis is a retrospective analysis of
       
  • Taxanes Hypersensitivity is not a risk factor for severe reactions to
           SARS-Cov-2 Vaccines

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. In our cohort Patients with history of reaction to taxanes were not at higher risk to develop anaphylaxis to SARS-CoV-2 vaccines. However, a common non-IgE mediated mechanism behind those HSRs cannot be completely excluded. This can only account for mild and harmless symptoms in case of SARS-CoV-2 vaccines. Antihistamine premedication and longer observation after the vaccination are still prudent in these patients.PMID:36047485
      DOI :10.23822/EurAnnACI.1764-1489.265 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 07 Sep 2022 16:39:46 +010
       
  • Prenatal antibiotic exposure increases the risk of infant atopic
           dermatitis. Data from a Greek cohort

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Αn increased risk of AD was recorded only when antibiotics were given prenatally by intravenous route and in women between 30-40 years of age. Children with food allergy had an increased risk for AD. The relatively high percentage of caesarean sections was not a risk factor for AD.PMID:36047711
      DOI :10.23822/EurAnnACI.1764-1489.266 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Wed, 07 Sep 2022 16:39:46 +010
       
  • Clinical evaluation of subcutaneous immunotherapy with a polymerized
           molecular allergoid of Alt a 1 in patients with allergic
           rhinoconjunctivitis and/or allergic asthma caused by the mould < em>
           Alternaria alternata < /em>

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Sep 1. doi: 10.23822/EurAnnACI.1764-1489.267. Online ahead of print.ABSTRACTThis is a retrospective analysis of the clinical evolution of 14 patients diagnosed with allergic rhinoconjunctivitis (AR) and/or allergic asthma (AA) caused by Alternaria alternata, who were attended by the allergology service of Vega Baja Hospital of Orihuela (Alicante, Spain). The purpose was to assess the clinical impact and safety of 1-year of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1. Impact of the treatment on allergic diseases (mean number AR/AA episodes and ARIA/GINA classifications), changes in symptoms and prescribed medication, change in the global subjective clinical status of patients and satisfaction with the treatment were also ev...
      PubDate: Wed, 07 Sep 2022 16:39:46 +010
      DOI: 10.23822/eurannaci.1764-1489.267. online ahead of print.abstractthis is a retrospective analysis of
       
  • Taxanes Hypersensitivity is not a risk factor for severe reactions to
           SARS-Cov-2 Vaccines

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. In our cohort Patients with history of reaction to taxanes were not at higher risk to develop anaphylaxis to SARS-CoV-2 vaccines. However, a common non-IgE mediated mechanism behind those HSRs cannot be completely excluded. This can only account for mild and harmless symptoms in case of SARS-CoV-2 vaccines. Antihistamine premedication and longer observation after the vaccination are still prudent in these patients.PMID:36047485
      DOI :10.23822/EurAnnACI.1764-1489.265 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
       
  • Prenatal antibiotic exposure increases the risk of infant atopic
           dermatitis. Data from a Greek cohort

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Αn increased risk of AD was recorded only when antibiotics were given prenatally by intravenous route and in women between 30-40 years of age. Children with food allergy had an increased risk for AD. The relatively high percentage of caesarean sections was not a risk factor for AD.PMID:36047711
      DOI :10.23822/EurAnnACI.1764-1489.266 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
       
  • Clinical evaluation of subcutaneous immunotherapy with a polymerized
           molecular allergoid of Alt a 1 in patients with allergic
           rhinoconjunctivitis and/or allergic asthma caused by the mould < em>
           Alternaria alternata < /em>

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Sep 1. doi: 10.23822/EurAnnACI.1764-1489.267. Online ahead of print.ABSTRACTThis is a retrospective analysis of the clinical evolution of 14 patients diagnosed with allergic rhinoconjunctivitis (AR) and/or allergic asthma (AA) caused by Alternaria alternata, who were attended by the allergology service of Vega Baja Hospital of Orihuela (Alicante, Spain). The purpose was to assess the clinical impact and safety of 1-year of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1. Impact of the treatment on allergic diseases (mean number AR/AA episodes and ARIA/GINA classifications), changes in symptoms and prescribed medication, change in the global subjective clinical status of patients and satisfaction with the treatment were also ev...
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
      DOI: 10.23822/eurannaci.1764-1489.267. online ahead of print.abstractthis is a retrospective analysis of
       
  • Taxanes Hypersensitivity is not a risk factor for severe reactions to
           SARS-Cov-2 Vaccines

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. In our cohort Patients with history of reaction to taxanes were not at higher risk to develop anaphylaxis to SARS-CoV-2 vaccines. However, a common non-IgE mediated mechanism behind those HSRs cannot be completely excluded. This can only account for mild and harmless symptoms in case of SARS-CoV-2 vaccines. Antihistamine premedication and longer observation after the vaccination are still prudent in these patients.PMID:36047485
      DOI :10.23822/EurAnnACI.1764-1489.265 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
       
  • Prenatal antibiotic exposure increases the risk of infant atopic
           dermatitis. Data from a Greek cohort

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Αn increased risk of AD was recorded only when antibiotics were given prenatally by intravenous route and in women between 30-40 years of age. Children with food allergy had an increased risk for AD. The relatively high percentage of caesarean sections was not a risk factor for AD.PMID:36047711
      DOI :10.23822/EurAnnACI.1764-1489.266 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
       
  • Clinical evaluation of subcutaneous immunotherapy with a polymerized
           molecular allergoid of Alt a 1 in patients with allergic
           rhinoconjunctivitis and/or allergic asthma caused by the mould < em>
           Alternaria alternata < /em>

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Sep 1. doi: 10.23822/EurAnnACI.1764-1489.267. Online ahead of print.ABSTRACTThis is a retrospective analysis of the clinical evolution of 14 patients diagnosed with allergic rhinoconjunctivitis (AR) and/or allergic asthma (AA) caused by Alternaria alternata, who were attended by the allergology service of Vega Baja Hospital of Orihuela (Alicante, Spain). The purpose was to assess the clinical impact and safety of 1-year of subcutaneous immunotherapy with a polymerized molecular allergoid of Alt a 1. Impact of the treatment on allergic diseases (mean number AR/AA episodes and ARIA/GINA classifications), changes in symptoms and prescribed medication, change in the global subjective clinical status of patients and satisfaction with the treatment were also ev...
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
      DOI: 10.23822/eurannaci.1764-1489.267. online ahead of print.abstractthis is a retrospective analysis of
       
  • Der p 23 sensitisation in patients with house dust mite respiratory
           allergy

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Der p 23 might be a prevalent allergen in regions with high rates of HDM exposure. Even though sIgE levels against this allergen are usually low, its presence could increase the risk of asthma.PMID:35899400
      DOI :10.23822/EurAnnACI.1764-1489.264 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 04 Sep 2022 20:33:05 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 31 Jul 2022 04:32:37 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Kounis Syndrome: an underestimated emergency

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The present study highlights the importance of suspicion of KS that appears not so uncommon in patients with anaphylaxis. KS seems to be a rare disease because unrecognized in diagnosis of anaphylaxis.PMID:35850501
      DOI :10.23822/EurAnnACI.1764-1489.260 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Bronchospasm and iodinated contrast media (ICM): an accurate evaluation is
           mandatory

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 18. doi: 10.23822/EurAnnACI.1764-1489.262. Online ahead of print.NO ABSTRACTPMID:35850502
      DOI :10.23822/EurAnnACI.1764-1489.262 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Can dose reduction be made in patients with allergic bronchopulmonary
           aspergillosis receiving high-dose omalizumab treatment'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Decreasing the total omalizumab dose does not cause clinical deterioration in ABPA after the disease is controlled.PMID:35850503
      DOI :10.23822/EurAnnACI.1764-1489.261 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • SARS-CoV-2 pandemics and RSV off-season outbreaks

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 9. doi: 10.23822/EurAnnACI.1764-1489.263. Online ahead of print.NO ABSTRACTPMID:35852514
      DOI :10.23822/EurAnnACI.1764-1489.263 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Concomitant evaluation of d-dimer and C-reactive protein in chronic
           spontaneous urticaria may show divergent values

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jul 4. doi: 10.23822/EurAnnACI.1764-1489.259. Online ahead of print.NO ABSTRACTPMID:35791699
      DOI :10.23822/EurAnnACI.1764-1489.259 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sun, 24 Jul 2022 00:30:40 +010
       
  • Contact sensitization in pediatric patients with atopic dermatitis: a
           purpose for a new patch testing serie for the Portuguese population

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jun 9. doi: 10.23822/EurAnnACI.1764-1489.258. Online ahead of print.ABSTRACTAtopic dermatitis is a common illness in pediatric age. Children with atopic dermatitis are prone to develop cutaneous sensitization due to skin barrier dysfunction and immune dysregulation. Recent studies have shown a higher prevalence of certain allergens, which identification may be clinically relevant and have implications for atopic dermatitis management. Considering the most prevalent and relevant allergens based on a retrospective analysis of 145 pediatric patients, 44.1% (n = 63) with atopic dermatitis, and comparing the positive results, we propose the application of an adapted baseline series with the most relevant 20 allergens for the Portuguese pediatric population wit...
      PubDate: Thu, 07 Jul 2022 00:48:42 +010
      DOI: 10.23822/eurannaci.1764-1489.258. online ahead of print.abstractatopic dermatitis is a common illnes
       
  • The impact of the COVID-19 pandemic in Hymenoptera Venom Immunotherapy: a
           single center experience

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Jun 9. doi: 10.23822/EurAnnACI.1764-1489.257. Online ahead of print.NO ABSTRACTPMID:35678606
      DOI :10.23822/EurAnnACI.1764-1489.257 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 11 Jun 2022 22:31:04 +010
       
  • Overview of asthma patients followed up in a Tertiary Clinic

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. Our study showed that different phenotypes were more closely related to some endotypes. This may allow the clinicians to identify patients and predict appropriate treatment modalities and response for individualized care.PMID:35670696
      DOI :10.23822/EurAnnACI.1764-1489.256 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 11 Jun 2022 22:31:04 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 11 Jun 2022 22:31:04 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 11 Jun 2022 22:31:04 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 11 Jun 2022 22:31:04 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Sat, 11 Jun 2022 22:31:04 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 06 Jun 2022 05:59:13 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Sustained unresponsiveness development in wheat oral immunotherapy:
           predictive factors and flexible regimen in the maintenance phase

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. The results revealed that the reduction of 50% sIgE is a predictive factor for SU in patients with IgE-mediated wheat allergy.PMID:35620981
      DOI :10.23822/EurAnnACI.1764-1489.254 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Factors associated with asthma exacerbations in schoolchildren: an
           experience in clinical practice

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 27. doi: 10.23822/EurAnnACI.1764-1489.255. Online ahead of print.NO ABSTRACTPMID:35620992
      DOI :10.23822/EurAnnACI.1764-1489.255 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Is polyethylene glycol allergy a real contraindication to COVID-19 mRNA
           vaccines'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 May 19. doi: 10.23822/EurAnnACI.1764-1489.253. Online ahead of print.NO ABSTRACTPMID:35586935
      DOI :10.23822/EurAnnACI.1764-1489.253 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Tue, 31 May 2022 13:08:13 +010
       
  • Pre-seasonal immunotherapy is effective in both monosensitized and
           polysensitized patients with allergic rhinitis

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Conclusions. This study indicates that clinical improvement with pre-seasonal grass pollen immunotherapy is accompanied by important increase in specific IgG4 blocking antibodies. Furthermore, a single-allergen immunotherapy can lead to similar clinical efficacy and immunological changes in polysensitized as well as monosensitized patients with grass pollen allergy.PMID:35448936
      DOI :10.23822/EurAnnACI.1764-1489.252 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Fri, 20 May 2022 07:01:26 +010
       
  • Nodular regenerative hyperplasia in CVID patients: could low-dose oral
           glucocorticoids be part of the solution'

    • Authors: European Annals of Allergy; Clinical Immunology
      Abstract: Eur Ann Allergy Clin Immunol. 2022 Mar 18. doi: 10.23822/EurAnnACI.1764-1489.251. Online ahead of print.NO ABSTRACTPMID:35301845
      DOI :10.23822/EurAnnACI.1764-1489.251 (Source: European Annals of Allergy and Clinical Immunology)
      PubDate: Mon, 25 Apr 2022 21:38:18 +010
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.237.29.69
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-